Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
Stocks Rise on Wall Street, Heading for Three-Day Rally
Stocks are rising more than 3% early Thursday, putting the market on track for its first three-day rally in six weeks, even as the astonishing scale of the downturn slamming the economy because of the coronavirus becomes more apparent.
On Hold: Tokyo Olympics Postponed to 2021
The IOC announced a first-of-its-kind postponement of the Summer Olympics on Tuesday, bowing to the realities of a coronavirus pandemic that is shutting down daily life around the globe and making planning for a massive worldwide gathering in July a virtual impossibility.
Load More